NCT06846086 (CEMC) is a Phase 3 clinical trial of Melatonin 10 MG in Cardiomyopathies, sponsored by Tanta University.

Who is sponsoring NCT06846086?

NCT06846086 is sponsored by Tanta University.

What drugs are being tested in NCT06846086?

Interventions in NCT06846086: Melatonin 10 MG, Placebo.

What condition does NCT06846086 study?

NCT06846086 studies Cardiomyopathies.

Is NCT06846086 still recruiting?

NCT06846086 is currently recruiting now. Last updated 26 March 2025.

Last reviewed 2025-03-26 · How we verify

NCT06846086: CEMC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

Recruiting now Phase 3 Last updated 26 March 2025

What this trial tests

Phase 3 trial testing Melatonin 10 MG in Cardiomyopathies in 46 participants. Currently enrolling.

Timeline

20 February 2025

Primary endpoint
1 January 2026

1 February 2026

Quick facts

Lead sponsor	Tanta University
Phase	Phase 3
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	46
Start date	20 February 2025
Primary completion	1 January 2026
Estimated completion	1 February 2026
Sites	1 location across Egypt

Drugs / interventions tested

Melatonin 10 MG — full drug profile →
Placebo

Conditions studied

Cardiomyopathies — all drugs for Cardiomyopathies →

Sponsor

Tanta University

Who can join

18 and older, any sex, with Cardiomyopathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of current study is to: Evaluate the cardioprotective effects of melatonin in patients with cardiomyopathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Melatonin 10 MG

Trials testing the same drug.

NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT06476392 — Melatonin fOr CHronic bAck Pain (The MOCHA Trial) · Phase 3 · active not recruiting
NCT06374771 — Analgesic Effect of Melatonin and Vitamin C Administration, Alone or In Combination in Major Abdominal Surgery. · NA · not yet recruiting
NCT05857046 — Cerebroprotective Effect of Melatonin in Stroke · Phase 3 · unknown
NCT04791943 — Preoperative Melatonin to Decrease Analgesia Usage After Third Molar Surgery · Phase 2 · completed

Other recruiting trials for Cardiomyopathies

Currently open trials in the same condition.

NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
NCT07359690 — Multimodal Analysis of Endomyocardial Biopsies · recruiting
NCT07006974 — SMCs With LVH Compared to HCM · active not recruiting
NCT06978998 — Validation of the Prognostic Impact of a Retinal Photograph-based Cardiovascular Disease Risk Stratification System in d · recruiting
NCT06446271 — Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH) · recruiting

Other Tanta University trials

Trials by the same sponsor.

NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06846086 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tanta University
Last refreshed: 26 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06846086.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing